PPP1R12A
Basic information
Region (hg38): 12:79773563-79935460
Previous symbols: [ "MYPT1" ]
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 22.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
NM_002480.3 | NP_002471.1 | 25 | yes | - |
ENST00000450142.7 | ENSP00000389168.2 | 25 | yes | - |
NM_001143885.2 | NP_001137357.1 | 25 | - | - |
NM_001143886.2 | NP_001137358.1 | 24 | - | - |
Phenotypes
GenCC
Source:
- genitourinary and/or brain malformation syndrome (Strong), mode of inheritance: AD
- genitourinary and/or brain malformation syndrome (Strong), mode of inheritance: AD
- genitourinary and/or brain malformation syndrome (Strong), mode of inheritance: AD
- genitourinary and/or brain malformation syndrome (Strong), mode of inheritance: AD
- genitourinary and/or brain malformation syndrome (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Genitourinary and/or/brain malformation syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Genitourinary; Gastrointestinal; Neurologic | 31883643 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (155 variants)
- Inborn_genetic_diseases (103 variants)
- Genitourinary_and/or_brain_malformation_syndrome (34 variants)
- PPP1R12A-related_disorder (15 variants)
- not_specified (8 variants)
- Differences_in_sex_development (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PPP1R12A gene is commonly pathogenic or not. These statistics are base on transcript: NM_002480.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 17 | 8 | 31 | ||
| missense | 4 | 138 | 30 | 7 | 179 | |
| nonsense | 4 | 5 | 9 | |||
| start loss | 1 | 1 | ||||
| frameshift | 9 | 8 | 1 | 18 | ||
| splice donor/acceptor (+/-2bp) | 1 | 6 | 5 | 1 | 13 | |
| Total | 14 | 23 | 151 | 48 | 15 |
Highest pathogenic variant AF is 0.00015245924
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PPP1R12A | protein_coding | protein_coding | ENST00000450142 | 25 | 161898 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 124534 | 0 | 28 | 124562 | 0.000112 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.64 | 342 | 509 | 0.671 | 0.0000254 | 6674 |
| Missense in Polyphen | 133 | 259.93 | 0.51167 | 3302 | ||
| Synonymous | 0.186 | 173 | 176 | 0.982 | 0.00000841 | 1942 |
| Loss of Function | 6.81 | 3 | 59.8 | 0.0501 | 0.00000338 | 772 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000198 | 0.000198 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000214 | 0.000213 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Key regulator of protein phosphatase 1C (PPP1C). Mediates binding to myosin. As part of the PPP1C complex, involved in dephosphorylation of PLK1. Capable of inhibiting HIF1AN- dependent suppression of HIF1A activity. {ECO:0000269|PubMed:18477460, ECO:0000269|PubMed:19245366, ECO:0000269|PubMed:20354225}.;
- Pathway
- Platelet activation - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Oxytocin signaling pathway - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Vascular smooth muscle contraction - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Focal Adhesion;Regulation of Actin Cytoskeleton;Signal Transduction;RHO GTPases Activate ROCKs;RHO GTPases activate PAKs;RHO GTPases activate PKNs;RHO GTPases activate CIT;RHO GTPase Effectors;Signaling by Rho GTPases;Regulation of PLK1 Activity at G2/M Transition;G2/M Transition;Mitotic G2-G2/M phases;Cell Cycle;TNFalpha;Integrin-linked kinase signaling;Cell Cycle, Mitotic;PLK1 signaling events;RhoA signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.418
Intolerance Scores
- loftool
- rvis_EVS
- -0.86
- rvis_percentile_EVS
- 10.85
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.329
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Zebrafish Information Network
- Gene name
- ppp1r12a
- Affected structure
- neuroepithelial cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased accumulation
Gene ontology
- Biological process
- mitotic cell cycle;protein dephosphorylation;centrosome cycle;signal transduction;regulation of cell adhesion;regulation of myosin-light-chain-phosphatase activity;positive regulation of myosin-light-chain-phosphatase activity;cellular response to drug;negative regulation of catalytic activity;positive regulation of transcription by RNA polymerase II;regulation of nucleocytoplasmic transport;regulation of establishment of endothelial barrier
- Cellular component
- kinetochore;nucleoplasm;cytoplasm;centrosome;cytosol;focal adhesion;actin cytoskeleton;Z disc;A band;contractile fiber;PTW/PP1 phosphatase complex
- Molecular function
- enzyme inhibitor activity;protein binding;phosphatase regulator activity;protein kinase binding;14-3-3 protein binding